By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ZyGem today said it has signed an agreement under which Morpho will market the firm's sample preparation and forensics analysis products to police forces worldwide.

The deal with Morpho, a subsidiary of the Safran Group that sells identity management and security control products, includes a strategic research and development collaboration. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.